• LAST PRICE
    3.2300
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (2.5397%)
  • Bid / Lots
    3.2400/ 9
  • Ask / Lots
    3.3300/ 9
  • Open / Previous Close
    3.1500 / 3.1500
  • Day Range
    Low 3.1000
    High 3.3900
  • 52 Week Range
    Low 2.6550
    High 20.4000
  • Volume
    301,266
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 3.15
TimeVolumeME
09:32 ET107443.15
09:33 ET18003.164
09:35 ET13333.19
09:37 ET19343.27
09:39 ET51583.298
09:42 ET60093.26
09:44 ET5003.23
09:48 ET73263.31
09:50 ET109423.365
09:51 ET133903.28
09:53 ET2003.31
09:55 ET14293.31
09:57 ET5733.318
10:00 ET29833.3636
10:02 ET12193.32
10:04 ET30673.33
10:06 ET8913.358
10:08 ET18623.3386
10:09 ET2003.333
10:13 ET8503.345
10:15 ET37883.37
10:18 ET8813.365
10:20 ET4003.36
10:22 ET72123.33
10:24 ET3583.33
10:26 ET1483.35
10:29 ET33343.31
10:31 ET19053.32
10:36 ET35323.27
10:40 ET2003.27
10:44 ET1003.285
10:45 ET2503.2707
10:51 ET3333.27
10:54 ET4003.28
10:56 ET5633.2701
10:58 ET30133.27
11:00 ET13973.29
11:02 ET3883.3
11:05 ET12003.3
11:07 ET3543.3
11:14 ET19503.305
11:16 ET1003.305
11:20 ET1003.305
11:21 ET4003.305
11:23 ET2003.305
11:27 ET7503.31
11:30 ET30003.34
11:32 ET6133.325
11:34 ET13003.36
11:36 ET3023.36
11:41 ET5003.34
11:54 ET3923.35
11:56 ET2133.37
11:59 ET20003.3531
12:01 ET10003.345
12:08 ET2003.345
12:10 ET6003.345
12:12 ET69053.38
12:14 ET3003.37
12:17 ET1003.38
12:35 ET13503.371
12:37 ET17913.38
12:39 ET3003.365
12:48 ET8993.37
12:50 ET1873.385
12:57 ET2003.38
01:02 ET40623.36
01:04 ET1003.3501
01:08 ET8123.35
01:09 ET8003.35
01:11 ET2093.34
01:13 ET2003.3401
01:15 ET3003.35
01:22 ET50003.3401
01:24 ET2503.3301
01:26 ET1003.3439
01:27 ET8003.33
01:29 ET78653.33
01:33 ET118413.32
01:36 ET10723.29
01:44 ET3003.27
01:45 ET4443.2957
01:47 ET13903.2734
01:49 ET2083.2775
01:51 ET4403.28
01:58 ET8563.26
02:00 ET5003.26
02:02 ET5513.26
02:05 ET15003.2876
02:16 ET2503.265
02:18 ET2503.25
02:25 ET15333.26
02:27 ET1003.27
02:32 ET2003.27
02:39 ET23503.27
02:43 ET2003.27
02:45 ET2003.285
02:50 ET6003.2681
02:52 ET11353.25
02:59 ET16003.24
03:06 ET32673.21
03:08 ET8053.21
03:10 ET3213.22
03:14 ET13483.23
03:15 ET1003.22
03:17 ET11523.23
03:19 ET3023.2401
03:21 ET104053.26
03:24 ET16983.265
03:26 ET42393.26
03:28 ET25403.2705
03:30 ET19303.28
03:32 ET46613.29
03:33 ET32643.31
03:37 ET12103.3
03:42 ET26003.2675
03:44 ET110213.225
03:46 ET13073.225
03:48 ET13383.26
03:50 ET8333.24
03:51 ET17683.23
03:53 ET11933.22
03:55 ET30513.2201
03:57 ET16603.215
04:00 ET76083.23
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesME
23andMe Holding Co.
75.9M
-0.1x
---
United StatesAMWL
American Well Corp
120.1M
-0.6x
---
United StatesXGN
Exagen Inc
73.0M
-4.2x
---
United StatesAUNA
Auna SA
520.4M
-7.9x
---
United StatesCCEL
Cryo-Cell International Inc
63.4M
-7.7x
---
United StatesNUTX
Nutex Health Inc
164.9M
-3.6x
---
As of 2024-11-22

Company Information

23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.

Contact Information

Headquarters
349 Oyster Point BoulevardSOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-938-6300
Fax
302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer, Co-Founder
Anne Wojcicki
Chief Financial and Accounting Officer
Joe Selsavage
Lead Independent Director
Mark Jensen
Independent Director
Andre Fernandez
Independent Director
Jim Frankola

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$75.9M
Revenue (TTM)
$193.3M
Shares Outstanding
24.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.18
EPS
$-25.27
Book Value
$7.69
P/E Ratio
-0.1x
Price/Sales (TTM)
0.4
Price/Cash Flow (TTM)
---
Operating Margin
-324.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.